Clinical Trials Search Results

AMG 757 20230298 Tarlatamab: A Phase 1b Study Evaluating Subcutaneous Tarlatamab in Subjects with Small Cell Lung Cancer

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery.

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

assess safety and efficacy of divarasib compared to sotorasib or adagrasib in participants with KRAS G12C + advanced or metastatic non-small cell lung cancer (NSCLC)

Non-Small Cell Lung Cancer Phase III Durvalumab Oleclumab Monalizumab Placebo

confirm Phase 2 dose (RP2D) of FF-10832 (Gemcitabine Liposome Injection) given Day 1 intravenously in combination with IV pembrolizumab Day 1 of same 21-day cycle

This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers.

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic NSCLC.

To determine if telisotuzumab vedotin works better than docetaxel & to assess how safe telisotuzumab vedotin is in adult participants w/ NSCLC who have previously been treated

This phase II/III trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizumab versus atezolizumab alone in patients who have already received atezolizumab plus chemotherapy for the treatment of small cell lung cancer that has spread outside of the lung or to other parts of the body (extensive stage).